Youssef Bouferraa

发表

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

H. Assi, Sabine Allam, Morgan Bou Zerdan, 2022, International journal of molecular sciences.

A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO)

D. Mukherji, S. Temraz, M. Charafeddine, 2022, BMC cancer.

The Gut Microbiome and Alzheimer's Disease: A Growing Relationship.

M. Yaghi, A. Nagarajan, Maria EL GEMAYEL, 2022, Current Alzheimer research.

From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade

A. Shamseddine, Ali H Abdel Sater, Y. Bouferraa, 2022, Frontiers in Oncology.

Total neoadjuvant therapy in patients with locally advanced rectal cancer: A tertiary medical center experience.

D. Mukherji, S. Temraz, M. Charafeddine, 2021, Molecular and clinical oncology.

Management of colorectal cancer in the era of COVID-19: Challenges and suggestions

D. Mukherji, A. Shamseddine, W. Alam, 2021, Science progress.

Metabolic Factors Affecting Tumor Immunogenicity: What Is Happening at the Cellular Level?

A. Shamseddine, R. El Sayed, Y. Bouferraa, 2021, International journal of molecular sciences.

Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma

S. Graziano, Sabine Allam, Morgan Bou Zerdan, 2022, Cancers.

The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges

D. Mukherji, S. Temraz, A. Shamseddine, 2021, International journal of molecular sciences.

The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study

D. Mukherji, S. Temraz, M. Charafeddine, 2022, BMC cancer.

The impact of young age (< 40 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study

D. Mukherji, S. Temraz, M. Charafeddine, 2022, BMC Cancer.

SO-30 Efficacy and safety of neoadjuvant short-course radiation followed by mFOLFOX-6 plus avelumab for locally-advanced rectal adenocarcinoma: Averectal study

F. Geara, J. Kattan, D. Mukherji, 2021, Annals of Oncology.

Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota

M. Bou Zerdan, Youssef Bouferraa, Callie Fares, 2023, International journal of molecular sciences.

Abstract. The current standard of care for locally advanced rectal cancer (LARC) includes preoperative chemoradiation, followed by total mesorectal excision and adjuvant chemo‐ therapy. This multimodality treatment improves local control but is associated with low compliance rates without clear bene

D. Mukherji, S. Temraz, M. Charafeddine, 2021 .

Thrombotic Microangiopathy in the Setting of Colorectal Cancer: A Therapeutic Challenge with a Bad Prognosis

R. Mahfouz, A. Shamseddine, Zaher Chakhachiro, 2023, Hematology reports.

Comparison Between Liver Stiffness Measurement by Fibroscan and Splenic Volume Index as NonInvasive Tools for the Early Detection of Oxaliplatin-induced Hepatotoxicity

D. Mukherji, S. Temraz, M. Charafeddine, 2021, Journal of clinical and experimental hepatology.

Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report

D. Gholam, Maroun Bou Zerdan, Y. Bouferraa, 2022, SAGE open medical case reports.

Systemic AL amyloidosis: current approach and future direction

S. Raza, C. Chaulagain, F. Anwer, 2023, Oncotarget.

Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane

A. Shamseddine, W. Alam, Y. Bouferraa, 2021, Clinical Medicine Insights. Oncology.